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Saudi Journal of Ophthalmology (2013) 27, 47–49Review ArticleCytomegalovirus-related corneal endotheliitis: A review articleAbdullah Alfawaz, MD, FRCS ⇑AbstractCytomegalovirus (CMV)-related corneal endotheliitis is an inflammation of the corneal endothelium caused by CMV. It typically
presents as coin-shaped keratic precipitates (KPs), with or without corneal edema, in otherwise healthy individuals. It may be asso-
ciated with anterior uveitis and raised intraocular pressure (IOP). Patients with CMV-related corneal endotheliitis respond to sys-
temic and topical ganciclovir with the use of topical steroid. Making an accurate early diagnosis is crucial in preventing loss of
corneal endothelial cells and unnecessary treatment resulting from misdiagnosis in these patients.
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Corneal endotheliitis, an inflammation of the corneal
endothelium, is characterized by corneal edema, keratic pre-
cipitates (KPs), and mild to moderate anterior chamber
inflammation. This clinical entity can be attributed to various
causes, all of which share a common site of inflammation—
corneal endothelial cells. Hence, inflammatory entities (e.g.,
epithelial keratitis and interstitial keratitis) that involve other
parts of the cornea—namely, the epithelium and the stro-
ma—do not fit the criterion of this disease. Corneal endothe-
liitis is caused by a variety of mechanisms, including immune-
related mechanisms without any known causative organisms
(e.g., graft rejection following penetrating keratoplasty) and
infectious mechanisms, such as those caused by viruses. Re-
search has shown that corneal endotheliitis can be caused
by herpes simplex virus (HSV), cytomegalovirus (CMV), vari-
cella zoster virus (VZV)19, and mumps infection23.
Human CMV, a ubiquitous lymphotropic herpes virus,
causes various systemic and ocular clinical entities, including
retinitis in immunocompromised hosts. Ocular CMV manifes-
tations range from corneal endotheliitis, episodic anteriorPeer review under responsibility
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and, ultimately, to retinitis. A few cases of CMV-related
corneal stromal13,28 and endothelial changes10,20 have
been reported in immunocompromised patients. Recent
research has shown an increasing number of cases of
CMV-associated anterior segment inflammation with a
different range of clinical presentations (including anterior
uveitis, corneal endotheliitis, or both) in otherwise healthy
individuals6,7,16,17,18,25,27. This is a review article that discusses
the pathology, diagnosis, and management of CMV-related
endotheliitis.Pathophysiology
The exact mechanism of corneal endotheliitis is not yet
clear. Research initially suggested that the mechanism of cor-
neal endotheliitis was autoimmune related, based on its sim-
ilarity with graft rejection and good response to topical
corticosteroid treatment15. However, with advances in diag-
nostic procedures, more recent research has indicated that
this clinical entity may be caused by viruses like CMV. One
possible explanation is that corneal endotheliitis is an autoim-Production and hosting by Elsevier
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Suzuki and Ohashi24 proposed that corneal endotheliitis is an
anterior chamber-associated immune deviation (ACAID)-re-
lated disease. They posited that a varied dose of virus is shed
into the anterior chamber whenever the virus that has estab-
lished a latent infection becomes intermittently reactivated.
Repeated shedding of virus particles leads to the induction
of ACAID against viral antigens. Infection occurs when the
preexisting antibodies are incapable of neutralizing the reac-
tivated virus. This mechanism could explain why some pa-
tients respond to topical anti-inflammatory treatment but
experience a relapse or recurrence after stopping the treat-
ment. By contrast, if the treatment regimen includes anti-
virus medication, patients with CMV-related corneal endo-
theliitis respond nicely.
Research has shown that murine CMV in immunocompe-
tent mice causes a transient, self-limited infection mainly in
the anterior segment, with only minimal involvement of the
posterior segment2. This finding could explain why most
CMV-related corneal endotheliitis and uveitis cases occur in
immunocompetent patients. The range of ocular manifesta-
tions of CMV and the variation between immunocompetent
and immune-deficient patients may depend on the ocular im-
mune response and/or the viral load. Hence, the anterior seg-
ment entities being the main mode of expression of infection
in relatively competent immune systems and posterior seg-
ment involvement in immunocompromised subjects4.Clinical features
The clinical features of corneal endotheliitis consist of KPs
and a corneal edema without the involvement of the other
corneal layers. Typically, CMV-related corneal endotheliitis
occurs in immunocompetent patients who are not afflicted
with any other diseases. Inflammation of the corneal endo-
thelium may or may not be associated with anterior uve-
itis7,18. High intraocular pressure (IOP) can occur in patients
with CMV-related corneal endotheliitis; its occurrence may
be related to inflammation of the trabecular meshwork. Koiz-
umi et al. 17 found that 7 of 8 (87%) of their patients with high
IOP responded nicely after treatment specific for CMV. In
addition, CMV-related corneal endotheliitis can mimic other
clinical entities. In some patients, it may present as chronic
anterior uveitis and recurrent episodic iritis with raised IOP,
resembling Posner-Schlossman syndrome (PSS), and in oth-
ers, it may present with anterior chamber cells and endothe-
lial KPs, resembling Fuchs’ heterochromic iridocyclitis (FHI)7.
Based on the distribution of the KPs and configuration of
the overlying stromal and epithelial edema, corneal endothe-
liitis can be classified into four forms: linear, sectorial, disci-
form, and diffuse. In both the linear and sectorial forms, the
corneal edema is localized; however, the distribution of KPs
differs—that is, it is linear in the former but is disseminated
to involve the area of the edema in the latter form. In disci-
form corneal endotheliitis, a round or disc-shaped stromal
edema is present in the central or paracentral region of the
cornea, and numerous KPs form inside the corneal edema.
In diffuse corneal endotheliitis, the edema is spread over
the entire cornea and fine KPs are scattered within the lesion.
CMV-related corneal endotheliitis rarely presents in the dif-
fuse form.Diagnosis
In general, corneal endotheliitis is a clinical diagnosis. Cor-
neal endotheliitis associated with specific coin-shaped KPs
could be used as a screening tool for CMV-related anterior
segment infection, especially if it is associated with high
IOP and corticosteroid-recalcitrant inflammation12. In cases
of CMV-related corneal endotheliitis, isolation of the virus
from the anterior chamber is necessary before starting the re-
quired treatment. Because the aqueous humor is generally
free from any pathogens, a positive result obtained by poly-
merase chain reaction (PCR) should be considered reliable
provided that contamination from the technique itself is ex-
cluded14. Anterior chamber fluid can be tested for the pres-
ence of viral DNA and local antibody production. A
combination of these tests is preferred because test results
can vary during the course of the disease21. Testing for
DNA tends to be positive at the onset (and/or early at reac-
tivation), and antibody testing can be positive at any point in
time. In general, the aqueous humor should be analyzed by
PCR for HSV, VZV, and CMV DNA21.
The Goldmann-Witmer coefficient (GWC) can also be cal-
culated for aqueous fluid so as to exclude the possibility of
passive diffusion from the patient serum. The GWC is defined
as titer of antibody in aqueous/titer of antibody in serum X
total serum globulins: total aqueous globulins11,21. A GWC
can be considered positive (i.e., suggestive of intraocular
antibody production) when the value exceeds 3. Detection
of corneal endothelial pathology (e.g., pseudoguttata or
owl’s eye) can sometimes be performed with in vivo confocal
microscopy22.Treatment
The treatment of CMV-related corneal endotheliitis should
target both its infectious and inflammatory components. One
rational strategy is appropriate systemic and antiviral treat-
ment with topical corticosteroids. Most current treatment
regimens are drawn from knowledge of CMV-related retinitis
in immunocompromised patients. Ganciclovir, a potent anti-
viral medication used to treat or prevent CMV infections
and other members of the herpes virus family, has been
widely used in its systemic form to treat CMV-related retinitis.
By inhibiting viral DNA polymerase, ganciclovir terminates
the elongation of viral DNA, which in turn arrests viral replica-
tion. Topical ganciclovir 0.15% gel has also been shown to be
effective in the treatment of active herpetic epithelial kerati-
tis8, in the prophylaxis against herpetic keratitis following ker-
atoplasty26, and in the treatment of CMV-related uveitis5.
Corneal penetration of topical ganciclovir is good and can
reach therapeutic levels in the aqueous humor3,9. Ganciclovir
given in gel form is easy to apply and seems to be a safe
alternative to the more toxic systemic form.
When Koizumi et al.17 used systemic ganciclovir to treat 8
patients with CMV-induced corneal endotheliitis, all patients
exhibited a quick clinical response to the treatment. In their
study, 7 patients received IV ganciclovir (5–10 mg/kg), and
1 patient received oral form valacyclovir (1500 mg/day). All
patients received topical corticosteroids; 4 patients received
0.3% topical acyclovir, 3–5 times per day, and the other 4 pa-
tients received 0.5% topical ganciclovir, 6–8 times per day. In
another study, Anshu et al.1 treated 4 patients who had been
Cytomegalovirus-related corneal endotheliitis: A review article 49diagnosed with CMV-related endotheliitis following Desc-
emet’s stripping automated endothelial keratoplasty
(DSAEK) with oral valganciclovir 900 mg twice daily for
6 weeks, followed by 900 mg once daily for a further 6 weeks.
Patients also received topical steroids, topical antiglaucoma
medications, and topical ganciclovir as needed. All patients
responded to treatment and grafts remained clear in 3 of
the 4 patients. After completion of treatment, 2 patients
had recurrence of inflammation, with mean time to recur-
rence of 8 months. Thus, CMV-related corneal endotheliitis
responds nicely to ganciclovir but can recur after discontinu-
ation of the treatment.
Physicians should inform patients about the potential for
hematologic toxicity secondary to systemic administration
of ganciclovir and, consequently, monitor patients periodi-
cally. If myelosuppression or pancytopenia occurs, the treat-
ment should be discontinued.
Conclusions
CMV-related corneal endotheliitis is manifested by corneal
edema in various locations, the presence of KPs, and a mild
anterior chamber reaction, and is usually associated with
raised IOP. Misdiagnoses and delays in treatment may occur
because CMV-related cornea endotheliitis can mimic other
clinical diagnoses. Further study is needed to investigate
other aspects of the disease, such as pathogenesis, ways of
prevention, and efficient treatment modalities.
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